Pharmaceutical Industry

FDA authorizes Novavax’s updated COVID vaccine targeting JN.1 strain

Tylenol maker Kenvue defeats U.S. lawsuit over labelling on ‘Rapid Release’ gelcaps

India’s Bharat Biotech to launch oral cholera vaccine amid global shortage

Business Brief: Human 2.0

Novartis receives binding offer from Siemens Healthineers for molecular imaging business

AI and Ozempic spell double trouble to the old economic order

Pharmacist pleads no contest to involuntary manslaughter in Michigan deaths from meningitis outbreak

Bavarian Nordic gets 440,000 dose contract to supply smallpox and mpox vaccines

Brookfield in talks with banks for funding Grifols’ takeover bid, sources say

Blast at Indian pharma factory kills 15 and injures 40, official says

Argentina quarantines grains ship over suspected mpox case

AstraZeneca gets US$107-million Pfizer verdict overturned in U.S. cancer drug patent fight

Ontario College of Pharmacists clears director of conflict of interest over Shoppers lawsuit

Seven U.S. dividend-payers to weather turbulent markets

Eli Lilly raises annual forecasts as quarterly sales of weight-loss drug cross US$1-billion

Novo Nordisk shares slide after rare miss on quarterly sales of obesity drug Wegovy

Japan’s Otsuka Pharma to pay up to $1.1-billion to acquire Jnana Therapeutics

Bristol Myers beat expectations with second-quarter results, helped by new drugs

AstraZeneca raises profit outlook on strong medicines demand

Agilent to buy contract drug manufacturer Biovectra for US$925-million